Lv11
90 积分 2022-08-17 加入
M1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study
2小时前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
14天前
已完结
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes
1个月前
已完结
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
2个月前
已完结
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study
9个月前
已完结
Cancer-Associated Hypercalcemia
11个月前
已完结
驱动基因阳性晚期非小细胞肺癌免疫治疗专家共识(2023版)
1年前
已完结
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial
1年前
已完结
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
1年前
已完结
Death-associated protein kinase 1 correlates with podocyte apoptosis and renal damage and can be mediated by miR-361
皖公网安备34019202002308
